Anti-MVD antibodies are used in the immunodetection of the protein mevalonate diphosphate decarboxylase. In humans, the canonical protein has a reported length of 400 amino acid residues and a mass of 43.4 kDa. Its subcellular localization is in the cytoplasm. It is found to be expressed in the heart, skeletal muscle, lung, liver, brain, pancreas, kidney and placenta. A member of the Diphosphomevalonate decarboxylase protein family, MVD is known to catalyze the ATP dependent decarboxylation of (R)-5-diphosphomevalonate to form isopentenyl diphosphate (IPP). Synonyms for this target antigen include MDDase, MPD, POROK7, diphosphomevalonate decarboxylase, mevalonate (diphospho) decarboxylase, and FP17780. MVD gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. A number of MVD antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. In addition, Immunohistochemistry is also a common application.